Introduction Mitochondrial dysfunction is increasingly recognised as one of the earliest drivers of ageing, metabolic disease and declining physical performance. As the cell's energy-producing organelles become less efficient, oxidative stress rises, ATP production falls, and tissues with high energy demands—including the heart, kidneys, brain and skeletal muscle—become increasingly vulnerable. One peptide attracting growing interest in longevity and mitochondrial research is

Mitochondrial health sits at the centre of nearly every longevity conversation. From energy production to metabolic flexibility and cellular resilience, the mitochondria ultimately determine how efficiently we age. One emerging intervention that has gained attention in both research and biohacking circles is MOTS-c, a mitochondrial-derived peptide believed to regulate metabolic stress and enhance cellular efficiency. While preclinical data is promising, real-world human data